Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
UBS
Accenture
Federal Trade Commission
Express Scripts
Chubb
US Department of Justice
Moodys
Queensland Health

Generated: December 19, 2018

DrugPatentWatch Database Preview

Drug Price Trends for IMATINIB MESYLATE

« Back to Dashboard

Drug Price Trends for IMATINIB MESYLATE

Average Pharmacy Cost for IMATINIB MESYLATE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
IMATINIB MESYLATE 100 MG TAB 00054-0248-22 6.08965 EA 2018-12-12
IMATINIB MESYLATE 400 MG TAB 00054-0249-13 19.03389 EA 2018-12-12
IMATINIB MESYLATE 400 MG TAB 60687-0203-95 19.03389 EA 2018-11-21
IMATINIB MESYLATE 400 MG TAB 00378-2246-93 19.03389 EA 2018-11-21
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for IMATINIB MESYLATE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
IMATINIB MESYLATE 100MG TAB Golden State Medical Supply, Inc. 60429-0925-90 90 1135.00 12.61111 EA 2017-02-27 - 2019-02-26 NC
IMATINIB MESYLATE 400MG TAB Golden State Medical Supply, Inc. 60429-0926-30 30 1375.00 45.83333 EA 2017-02-27 - 2019-02-26 NC
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
McKesson
Dow
Mallinckrodt
Deloitte
Federal Trade Commission
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.